Real-world evidence of treatment outcomes in mantle cell lymphoma: A single-center experience in southern Taiwan

Treatment outcomes in hormone receptor-positive, HER2-negative metastatic breast cancer patients with and without progression after completion of reimbursed cyclin-dependent kinase 4/6 inhibitors in Taiwan: A single-institution experience

Does genetic testing influence outcomes: Early experience in melanoma case series

Unusual presentation of secondary chronic myeloid leukemia in a metastatic breast cancer patient receiving cyclin-dependent kinase 4/6 inhibitor therapy: A case report

Pembrolizumab-induced Guillain–Barré syndrome in early-stage triple-negative metaplastic breast cancer responded to intravenous immunoglobulin and steroids: A case report

A long-standing perianal fistula hiding an adenocarcinoma: A case report

Acquired resistance in BRAF V600E-Mutant MSS colorectal cancer: Two cases highlighting molecular adaptation and salvage strategies